Boston Heart Diagnostics
Kara Coduri has a background in medical laboratory science and has worked for multiple healthcare organizations. Kara started their career at Beth Israel Deaconess Medical Center in 2007 as a Medical Laboratory Professional and worked there until 2012. Kara then joined MIT Medical in 2012 and served as a Medical Laboratory Scientist until 2016. Currently, they are employed at Boston Heart Diagnostics, where they started in 2016 as a Medical Laboratory Scientist and has since been promoted to the position of Clinical Laboratory Supervisor in April 2021.
Kara Coduri pursued their education at UMass Dartmouth, where they completed their Bachelor of Science (B.S.) in Medical Laboratory Science. However, there is no specific information available regarding the duration of their studies or the years they attended the institution.
Boston Heart Diagnostics
Boston Heart Lab is a healthcare company that provides cardiovascular disease (CVD) management. Through there combination of proprietary lipid testing capability, sophisticated tools, advanced therapy guidelines, and patient support services, they are providing physicians, patients, and pharmaceutical companies with viable disease management.Unlike other lipid testing companies that are focused on the primary screening market for CVD, their proprietary testing technology allows for the ongoing monitoring of a patient's disease and precise determination of the most appropriate pharmaceutical alternatives. They can provide unique, personalized treatment options to patients with dyslipidemia to determine the efficacy of lipid adjusting drugs in most cases within the first 6 weeks of treatment. Competing methods usually need 6 months.